Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Denver news in your inbox
Catch up on the most important stories affecting your hometown with Axios Denver
Des Moines news in your inbox
Catch up on the most important stories affecting your hometown with Axios Des Moines
Minneapolis-St. Paul news in your inbox
Catch up on the most important stories affecting your hometown with Axios Twin Cities
Tampa Bay news in your inbox
Catch up on the most important stories affecting your hometown with Axios Tampa Bay
Charlotte news in your inbox
Catch up on the most important stories affecting your hometown with Axios Charlotte
HHS Secretary Alex Azar. Photo: Alex Wong/Getty Images
The Trump administration announced Wednesday that it is taking steps to open the door for prescription drugs to be imported into the U.S. from other countries.
The big picture: Drug importation has long been a policy idea championed mostly by Democrats, but there are plenty of reasons to be skeptical that it'll have much of an impact on drug prices — beginning with other countries' lack of enthusiasm for sending us their drugs.
Go deeper: Importing prescription drugs from Canada is tougher than it sounds